Association of miR-146a rs2910164 polymorphism with cardio-cerebrovascular diseases: A systematic review and meta-analysis

Gene

Volumn 565, Issue 2, 2015, Pages 171-179

  He, Yuqing ^a   Yang, Jie ^a   Kong, Danli ^a   Lin, Juanjuan ^a   Xu, Chengkai ^a   Ren, Han ^a   Ouyang, Ping ^a   Ding, Yuanlin ^a   Wang, Kai ^b  

^a GUANGDONG MEDICAL UNIVERSITY   (China)

^b INSTITUTE FOR SYSTEMS BIOLOGY   (United States)

Author keywords

Cardiovascular diseases; Cerebrovascular diseases; Coronary artery disease (CAD); MicroRNA; MicroRNA146a; Single nucleotide polymorphism

Indexed keywords

MICRORNA 146A; MICRORNA; MIRN146 MICRORNA, HUMAN;

ALLELE; ANALYSIS; ARTICLE; CARDIOCEREBROVASCULAR DISEASE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CEREBROVASCULAR DISEASE; CHINESE; CORONARY ARTERY DISEASE; DNA POLYMORPHISM; DOMINANT GENE; ETHNICITY; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; GENETIC MODEL; GENOTYPE; HEART DISEASE; HEART FUNCTION; HEART PROTECTION; HETEROZYGOTE; HOMOZYGOTE; HUMAN; INDIAN; KOREAN (PEOPLE); META ANALYSIS (TOPIC); PATHWAY ENRICHMENT ANALYSIS; PRIORITY JOURNAL; RECESSIVE GENE; RISK ASSESSMENT; RISK FACTOR; RNA ANALYSIS; SENSITIVITY ANALYSIS; SYSTEMATIC REVIEW; ASIAN CONTINENTAL ANCESTRY GROUP; CASE CONTROL STUDY; GENETIC PREDISPOSITION; GENETICS; META ANALYSIS; RISK; SINGLE NUCLEOTIDE POLYMORPHISM;

ALLELES; ASIAN CONTINENTAL ANCESTRY GROUP; CARDIOVASCULAR DISEASES; CASE-CONTROL STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MICRORNAS; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK; RISK FACTORS;

EID: 84929044945     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2015.04.020     Document Type: Article

References (45)

1. Alshatwi A.A., Shafi G., Hasan T.N., Syed N.A., Al-Hazzani A.A., Alsaif M.A., Alsaif A.A. Differential expression profile and genetic variants of microRNAs sequences in breast cancer patients. PLoS One 2012, 7:e30049.
2. Bhattacharya A., Ziebarth J.D., Cui Y. Systematic analysis of microRNA targeting impacted by small insertions and deletions in human genome. PLoS One 2012, 7:e46176.
3. Bhaumik D., Scott G.K., Schokrpur S., Patil C.K., Campisi J., Benz C.C. Expression of microRNA-146 suppresses NF-kappaB activity with reduction of metastatic potential in breast cancer cells. Oncogene 2008, 27:5643-5647.
4. Chassin C., Hempel C., Stockinger S., Dupont A., Kubler J.F., Wedemeyer J., Vandewalle A., Hornef M.W. MicroRNA-146a-mediated downregulation of IRAK1 protects mouse and human small intestine against ischemia/reperfusion injury. EMBO Mol. Med. 2012, 4:1308-1319.
5. Chen L., Wu Y.T. Association of genetic polymorphisms in microRNAs precursor with the risk and prognosis of coronary heart disease. J. Xi'an Jiaotong Univ. (Med. Sci.) 2013, 34:495-499.
6. Chen C., Hong H., Chen L., Shi X., Chen Y., Weng Q. Association of microRNA polymorphisms with the risk of myocardial infarction in a Chinese population. Tohoku J. Exp. Med. 2014, 233:89-94.
7. Cipollini M., Landi S., Gemignani F. MicroRNA binding site polymorphisms as biomarkers in cancer management and research. Pharmgenomics Pers. Med. 2014, 7:173-191.
8. Cui L., Li Y., Ma G., Wang Y., Cai Y., Liu S., Chen Y., Li J., Xie Y., Liu G., Zhao B., Li K. A functional polymorphism in the promoter region of microRNA-146a is associated with the risk of Alzheimer disease and the rate of cognitive decline in patients. PLoS One 2014, 9:e89019.
9. Dong S., Xiong W., Yuan J., Li J., Liu J., Xu X. MiRNA-146a regulates the maturation and differentiation of vascular smooth muscle cells by targeting NF-kappaB expression. Mol. Med. Rep. 2013, 8:407-412.
10. Ebert M.S., Sharp P.A. Roles for microRNAs in conferring robustness to biological processes. Cell 2012, 149:515-524.
11. El Gazzar M., Church A., Liu T., McCall C.E. MicroRNA-146a regulates both transcription silencing and translation disruption of TNF-alpha during TLR4-induced gene reprogramming. J. Leukoc. Biol. 2011, 90:509-519.
12. Guo M., Mao X., Ji Q., Lang M., Li S., Peng Y., Zhou W., Xiong B., Zeng Q. miR-146a in PBMCs modulates Th1 function in patients with acute coronary syndrome. Immunol. Cell Biol. 2010, 88:555-564.
13. Hashemi M., Eskandari-Nasab E., Zakeri Z., Atabaki M., Bahari G., Jahantigh M., Taheri M., Ghavami S. Association of pre-miRNA-146a rs2910164 and premiRNA-499 rs3746444 polymorphisms and susceptibility to rheumatoid arthritis. Mol. Med. Rep. 2013, 7:287-291.
14. Hogg D.R., Harries L.W. Human genetic variation and its effect on miRNA biogenesis, activity and function. Biochem. Soc. Trans. 2014, 42:1184-1189.
15. Huang S., Zhou S., Zhang Y., Lv Z., Li S., Xie C., Ke Y., Deng P., Geng Y., Zhang Q., Chu X., Yi Z., Wu T., Cheng J. Association of the genetic polymorphisms in pre-microRNAs with risk of ischemic stroke in a Chinese Population. PLoS One 2015, 10:e0117007.
16. Jazdzewski K., Murray E.L., Franssila K., Jarzab B., Schoenberg D.R., de la Chapelle A. Common SNP in pre-miR-146a decreases mature miR expression and predisposes to papillary thyroid carcinoma. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:7269-7274.
17. Jeon Y.J., Kim O.J., Kim S.Y., Oh S.H., Oh D., Shin B.S., Kim N.K. Association of the miR-146a, miR-149, miR-196a2, and miR-499 polymorphisms with ischemic stroke and silent brain infarction risk. Arterioscler. Thromb. Vasc. Biol. 2013, 33:420-430.
18. Jeon H.-S., Lee Y.H., Lee S.Y., Jang J.-A., Choi Y.-Y., Yoo S.S., Lee W.K., Choi J.E., Son J.W., Kang Y.M. A common polymorphism in pre-microRNA-146a is associated with lung cancer risk in a Korean population. Gene 2014, 534:66-71.
19. Johnson C.Y., Flanders W.D., Strickland M.J., Honein M.A., Howards P.P. Potential sensitivity of bias analysis results to incorrect assumptions of nondifferential or differential binary exposure misclassification. Epidemiology 2014, 25:902-909.
20. Kangas-Kontio T., Huotari A., Ruotsalainen H., Herzig K.H., Tamminen M., Ala-Korpela M., Savolainen M.J., Kakko S. Genetic and environmental determinants of total and high-molecular weight adiponectin in families with low HDL-cholesterol and early onset coronary heart disease. Atherosclerosis 2010, 210:479-485.
21. Kones R. Molecular sources of residual cardiovascular risk, clinical signals, and innovative solutions: relationship with subclinical disease, undertreatment, and poor adherence: implications of new evidence upon optimizing cardiovascular patient outcomes. Vasc. Health Risk Manag. 2013, 9:617-670.
22. Lederhuber H., Baer K., Altiok I., Sadeghi K., Herkner K.R., Kasper D.C. MicroRNA-146: tiny player in neonatal innate immunity?. Neonatology 2011, 99:51-56.
23. Li Y., Zhu J., Ma G.D., Li K.S., Gui L.L. Association between miR-146a gene polymorphism and lacunar infarction. Shandong Med. J. 2014, 54:1-3.
24. Lian H., Wang L., Zhang J. Increased risk of breast cancer associated with CC genotype of Has-miR-146a Rs2910164 polymorphism in Europeans. PLoS One 2012, 7:e31615.
25. Liu Y., Ma Y., Zhang B., Wang S.X., Wang X.M., Yu J.M. Genetic polymorphisms in pre-microRNAs and risk of ischemic stroke in a Chinese population. J. Mol. Neurosci. 2014, 52:473-480.
26. Ma X.P., Zhang T., Peng B., Yu L., Jiang de K. Association between microRNA polymorphisms and cancer risk based on the findings of 66 case-control studies. PLoS One 2013, 8:e79584.
27. Mohnle P., Schutz S.V., van der Heide V., Hubner M., Luchting B., Sedlbauer J., Limbeck E., Hinske L.C., Briegel J., Kreth S. MicroRNA-146a controls Th1-cell differentiation of human CD4+ T lymphocytes by targeting PRKCepsilon. Eur. J. Immunol. 2015, 45:260-272.
28. Moran A.E., Roth G.A., Narula J., Mensah G.A. 1990-2010 global cardiovascular disease atlas. Glob. Heart 2014, 9:3-16.
29. Olivieri F., Lazzarini R., Recchioni R., Marcheselli F., Rippo M.R., Di Nuzzo S., Albertini M.C., Graciotti L., Babini L., Mariotti S., Spada G., Abbatecola A.M., Antonicelli R., Franceschi C., Procopio A.D. MiR-146a as marker of senescence-associated pro-inflammatory status in cells involved in vascular remodelling. Age 2013, 35:1157-1172.
30. Raitoharju E., Lyytikainen L.P., Levula M., Oksala N., Mennander A., Tarkka M., Klopp N., Illig T., Kahonen M., Karhunen P.J., Laaksonen R., Lehtimaki T. miR-21, miR-210, miR-34a, and miR-146a/b are up-regulated in human atherosclerotic plaques in the Tampere Vascular Study. Atherosclerosis 2011, 219:211-217.
31. Ramkaran P., Khan S., Phulukdaree A., Moodley D., Chuturgoon A.A. miR-146a polymorphism influences levels of miR-146a, IRAK-1, and TRAF-6 in young patients with coronary artery disease. Cell Biochem. Biophys. 2014, 68:259-266.
32. Roberts R., Stewart A.F. Genes and coronary artery disease: where are we?. J. Am. Coll. Cardiol. 2012, 60:1715-1721.
33. Saba R., Gushue S., Huzarewich R.L., Manguiat K., Medina S., Robertson C., Booth S.A. MicroRNA 146a (miR-146a) is over-expressed during prion disease and modulates the innate immune response and the microglial activation state. PLoS One 2012, 7:e30832.
34. Sheu J.R., Thomas P.A., Cheng J.T. Novel drugs development for cardio-/cerebrovascular diseases. BioMed Res. Int. 2014, 2014:467936.
35. Taganov K.D., Boldin M.P., Chang K.J., Baltimore D. NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:12481-12486.
36. Trikalinos T.A., Salanti G., Khoury M.J., Ioannidis J.P. Impact of violations and deviations in Hardy-Weinberg equilibrium on postulated gene-disease associations. Am. J. Epidemiol. 2006, 163:300-309.
37. Wang A.X., Xu B., Tong N., Chen S.Q., Yang Y., Zhang X.W., Jiang H., Liu N., Liu J., Hu X.N., Sha G.Z., Chen M. Meta-analysis confirms that a common G/C variant in the pre-miR-146a gene contributes to cancer susceptibility and that ethnicity, gender and smoking status are risk factors. Genet. Mol. Res. 2012, 11:3051-3062.
38. Wang Z.H., Liu R., Gu H.Y. Association study of miR-146a rs2910164 C>G polymorphism and risk of congenital heart disease. J. Clin. Exp. Med. 2013, 12:729-733.
39. Woolf B. On estimating the relation between blood group and disease. Ann. Hum. Genet. 1955, 19:251-253.
40. Xiong X.D., Cho M., Cai X.P., Cheng J., Jing X., Cen J.M., Liu X., Yang X.L., Suh Y. A common variant in pre-miR-146 is associated with coronary artery disease risk and its mature miRNA expression. Mutat. Res. Fundam. Mol. Mech. Mutagen. 2014, 761:15-20.
41. Xu J., Hu Z., Xu Z., Gu H., Yi L., Cao H., Chen J., Tian T., Liang J., Lin Y., Qiu W., Ma H., Shen H., Chen Y. Functional variant in microRNA-196a2 contributes to the susceptibility of congenital heart disease in a Chinese population. Hum. Mutat. 2009, 30:1231-1236.
42. Zdravkovic S., Wienke A., Pedersen N.L., Marenberg M.E., Yashin A.I., De Faire U. Heritability of death from coronary heart disease: a 36-year follow-up of 20966 Swedish twins. J. Intern. Med. 2002, 252:247-254.
43. Zhang L., Chopp M., Liu X., Teng H., Tang T., Kassis H., Zhang Z.G. Combination therapy with VELCADE and tissue plasminogen activator is neuroprotective in aged rats after stroke and targets microRNA-146a and the toll-like receptor signaling pathway. Arterioscler. Thromb. Vasc. Biol. 2012, 32:1856-1864.
44. Zhou B., Rao L., Peng Y., Wang Y., Chen Y., Song Y., Zhang L. Common genetic polymorphisms in pre-microRNAs were associated with increased risk of dilated cardiomyopathy. Clin. Chim. Acta 2010, 411:1287-1290.
45. Zhu R., Liu X., He Z., Li Q. miR-146a and miR-196a2 polymorphisms in patients with ischemic stroke in the northern Chinese Han population. Neurochem. Res. 2014, 39:1709-1716.